@article{439c9be8f7e24abebf31b7dae3f09ab3,
title = "NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma",
author = "M. Hao and R. Franqui-Machin and H. Xu and J. Shaughnessy and B. Barlogie and D. Roodman and Quelle, \{D. E.\} and S. Janz and Tomasson, \{M. H.\} and Sanderson, \{R. D.\} and L. Qiu and I. Frech and G. Tricot and F. Zhan",
note = "Funding Information: I thank Sigma-tau Research Switzerland (Mendriso, CH) for providing the heparanase inhibitor Roneparstat. The data presented in this article were obtained at the Preclinical Imaging Shared Resource Facility, which is a Carver College of Medicine/Holden Comprehensive Cancer Center core research facility at the University of Iowa. The Facility is funded through user fees and the generous financial support of the Carver College of Medicine, Holden Comprehensive Cancer Center, and Iowa City Veteran's Administration Medical Center. This work was supported by NIH grants R01CA152105 (FZ), R21CA143887 (FZ), R01CA138340 (RS), the Leukemia \& Lymphoma Society TRP (6094-12), the Multiple Myeloma Research Foundation (FZ), the International Myeloma Foundation (FZ), the American Society of Hemathology (ASH) Bridge (FZ), and institutional start-up funds from the Department of Internal Medicine, Carver College of Medicine, University of Iowa (FZ and GT).",
year = "2017",
month = jul,
day = "1",
doi = "10.1038/leu.2017.115",
language = "English",
volume = "31",
pages = "1648--1650",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "7",
}